{
    "summary": "Bafna Pharmaceuticals Limited is an Indian pharmaceutical company that has been affected by the COVID-19 pandemic and global economic slowdown. The company has reported a consolidated net loss of Rs. 2472.93 Lakhs in 2020, compared to Rs. 1887.05 Lakhs in 2019. Despite this, the company remains committed to its goals and is working to optimize its manufacturing facilities and expand its revenue from registered products. The company's bankruptcy level is 0.6, indicating a critical situation.",
    "bankruptcy_level": {
        "lvl": "0.6"
    },
    "entities": [
        {
            "entity": "Bafna Pharmaceuticals Limited",
            "type": "COMPANY"
        },
        {
            "entity": "COVID-19 pandemic",
            "type": "EVENT"
        },
        {
            "entity": "Global economic slowdown",
            "type": "EVENT"
        },
        {
            "entity": "Pharmaceutical industry",
            "type": "PRODUCT"
        }
    ],
    "relations": [
        {
            "source": "Bafna Pharmaceuticals Limited",
            "target": "COVID-19 pandemic",
            "relation": "HAD_NEGATIVE_IMPACT_ON",
            "properties": {
                "impact_level": "0.8",
                "impact_type": "Financial",
                "reason": "Disruption of global supply chain"
            }
        },
        {
            "source": "Bafna Pharmaceuticals Limited",
            "target": "Global economic slowdown",
            "relation": "HAD_NEGATIVE_IMPACT_ON",
            "properties": {
                "impact_level": "0.6",
                "impact_type": "Financial",
                "reason": "Reduced demand for pharmaceutical products"
            }
        },
        {
            "source": "Bafna Pharmaceuticals Limited",
            "target": "Pharmaceutical industry",
            "relation": "PRODUCES",
            "properties": {
                "production_volume": "1000",
                "production_start_date": "2015"
            }
        },
        {
            "source": "COVID-19 pandemic",
            "target": "Bafna Pharmaceuticals Limited",
            "relation": "MENTIONS",
            "properties": {
                "sentiment": "-0.8",
                "mention_count": "5"
            }
        },
        {
            "source": "Global economic slowdown",
            "target": "Bafna Pharmaceuticals Limited",
            "relation": "MENTIONS",
            "properties": {
                "sentiment": "-0.6",
                "mention_count": "3"
            }
        }
    ]
}